SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹6.17 Cr | ₹4.28 Cr | - | - | - |
What is the latest Contingent Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹6.17 Cr |
| Mar2024 | ₹4.28 Cr |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Contingent Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.17 Cr | 43.95 | |
| Mar2024 | ₹4.28 Cr | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,623.2 Cr | -4.6% | -9.7% | 15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -4.6% |
-9.7% |
15.2% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses